Literature DB >> 31233197

HIF‑1α promotes the stemness of oesophageal squamous cell carcinoma by activating the Wnt/β‑catenin pathway.

Zhuan Lv1, Rui-Dong Liu2, Xiao-Qi Chen3, Bing Wang4, Li-Feng Li5, Ying-Shu Guo1, Xin-Ju Chen3, Xian-Qing Ren1.   

Abstract

Hypoxia‑inducible‑factor 1α (HIF‑1α) is a marker for poor prognosis in the majority of the cancer types, and it has been revealed to be essential for maintaining cancer stem cells (CSCs). In the present study, it was determined that the expression of HIF‑1α and CSC‑related genes under hypoxic conditions was upregulated. Stable knockdown of HIF‑1α significantly inhibited cell proliferation, migration and tumour growth in vivo in oesophageal squamous cell carcinoma (ESCC). A previous study revealed that the Wnt/β‑catenin pathway may play a key role in maintenance and progression of CSCs. Therefore, it was also revealed that stable knockdown of HIF‑1α reduced the formation of spheroid body cells, the expression of CSC‑related genes and Wnt/β‑catenin pathway‑related target genes, as well as the activity of the Wnt/β‑catenin pathway. Collectively, the present results indicated that HIF‑1α may regulate the stemness of ESCC by activating the Wnt/β‑catenin pathway.

Entities:  

Year:  2019        PMID: 31233197     DOI: 10.3892/or.2019.7203

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  8 in total

1.  Human umbilical cord mesenchymal stem cell-derived extracellular vesicles carrying miR-655-3p inhibit the development of esophageal cancer by regulating the expression of HIF-1α via a LMO4/HDAC2-dependent mechanism.

Authors:  Mingjiu Chen; Zhenkun Xia; Jie Deng
Journal:  Cell Biol Toxicol       Date:  2022-10-12       Impact factor: 6.819

2.  Expression of HIF-1α, ANXA3, CD133 and their associations with clinicopathological parameters in human colon carcinoma.

Authors:  Xiaoyan Chai; Xiao Wu; Jiahui Ren; Kunli Du; Xingye Wu; Fan Feng; Jianyong Zheng
Journal:  Transl Cancer Res       Date:  2022-06       Impact factor: 0.496

Review 3.  Linking Cancer Stem Cell Plasticity to Therapeutic Resistance-Mechanism and Novel Therapeutic Strategies in Esophageal Cancer.

Authors:  Chenghui Zhou; Ningbo Fan; Fanyu Liu; Nan Fang; Patrick S Plum; René Thieme; Ines Gockel; Sascha Gromnitza; Axel M Hillmer; Seung-Hun Chon; Hans A Schlösser; Christiane J Bruns; Yue Zhao
Journal:  Cells       Date:  2020-06-17       Impact factor: 6.600

4.  Hypoxia-induced Tie1 drives stemness and cisplatin resistance in non-small cell lung carcinoma cells.

Authors:  Chaojie Li; Nannan Yang; Zhijin Chen; Ning Xia; Qungang Shan; Ziyin Wang; Jian Lu; Mingyi Shang; Zhongmin Wang
Journal:  Cancer Cell Int       Date:  2021-01-18       Impact factor: 5.722

Review 5.  Therapeutic Strategies Against Cancer Stem Cells in Esophageal Carcinomas.

Authors:  Plabon Kumar Das; Farhadul Islam; Robert A Smith; Alfred K Lam
Journal:  Front Oncol       Date:  2021-02-16       Impact factor: 6.244

6.  Construction and Verification of a Hypoxia-Stemness-Based Gene Signature for Risk Stratification in Esophageal Cancer.

Authors:  Kang Tang; Yong Cheng; Qian Li
Journal:  Med Sci Monit       Date:  2021-10-30

7.  Development and validation of a hypoxia-stemness-based prognostic signature in pancreatic adenocarcinoma.

Authors:  Xiong Tian; Jing Zheng; Wanlan Mou; Guoguang Lu; Shuaishuai Chen; Juping Du; Yufen Zheng; Shiyong Chen; Bo Shen; Jun Li; Na Wang
Journal:  Front Pharmacol       Date:  2022-07-21       Impact factor: 5.988

8.  Role of hypoxia inducible factor-1 in cancer stem cells (Review).

Authors:  Qi Zhang; Zhenzhen Han; Yanbo Zhu; Jingcheng Chen; Wei Li
Journal:  Mol Med Rep       Date:  2020-11-12       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.